Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amanda M. Saracino"'
Publikováno v:
Journal of the American Academy of Dermatology. 87:937-954
Systemic sclerosis (SSc), also referred to as systemic scleroderma or scleroderma, is a rare, complex immune-mediated connective tissue disease characterized by progressive skin fibrosis and other clinically heterogenous features. The etiopathogenesi
Autor:
Jessica L. Fairley, Mandana Nikpour, Heather G. Mack, Maria Brosnan, Amanda M. Saracino, Marc Pellegrini, Ian P. Wicks
Publikováno v:
Internal Medicine Journal. 53:311-317
Hydroxychloroquine (HCQ) and its close relative chloroquine (CQ) were initially used as antimalarial agents but are now widely prescribed in rheumatology, dermatology and immunology for the management of autoimmune diseases. HCQ is considered to have
Autor:
Amanda M. Saracino, Daniel Kelberman, Georg W. Otto, Andrey Gagunashvili, David J. Abraham, Christopher P. Denton
Publikováno v:
Archives of Dermatological Research.
Background Morphoea can have a significant disease burden. Aetiopathogenesis remains poorly understood, with very limited existing genetic studies. Linear morphoea (LM) may follow Blascho’s lines of epidermal development, providing potential pathog
Autor:
Amanda M. Saracino, Mandana Nikpour
Publikováno v:
JAMA Dermatology. 159:249
Publikováno v:
Journal of the American Academy of Dermatology. 87(5)
The management of systemic sclerosis (SSc) is complex, evolving, and requires a multidisciplinary approach. At diagnosis and throughout the disease course, clinical assessment and monitoring of skin involvement is vital using the modified Rodnan Skin
Publikováno v:
JAMA Dermatology. 154:1432
Importance Cutaneous lupus erythematosus (CLE) can be severe and treatment resistant. B-cell depletion therapy (BCDT) with rituximab is well recognized in organ involvement in systemic lupus erythematosus (SLE), but its efficacy in cutaneous manifest